Skip to content

10x Genomics

US · TXG #1311 by market cap Listed 2019
51.80 -5.58 -9.72%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Recent news

  • Rating change
    J.P. Morgan Remains a Hold on 10x Genomics (TXG)
    TipRanks · 2026/8/11
  • Rating change
    Citi Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $45
    Market Newswire · 2026/7/8
  • Stephens Initiates 10x Genomics(TXG.US) With Hold Rating, Announces Target Price $65
    Market Newswire · 2026/11/12
  • Rating change
    Barclays Maintains 10x Genomics(TXG.US) With Buy Rating, Raises Target Price to $110
    Market Newswire · 2026/10/7
  • Barclays Maintains 10x Genomics(TXG.US) With Buy Rating, Maintains Target Price $70
    Market Newswire · 2026/11/9
  • Rating change
    CCORF Maintains 10x Genomics(TXG.US) With Buy Rating, Raises Target Price to $100
    Market Newswire · 2026/10/12
  • Rating change
    Piper Sandler Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $42
    Market Newswire · 2026/7/1
  • Rating change
    Citi Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $50
    Market Newswire · 2026/8/7
  • Rating change
    CCORF Maintains 10x Genomics(TXG.US) With Buy Rating, Raises Target Price to $50
    Market Newswire · 2026/7/14
  • Rating change
    RBC Capital Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $70
    Market Newswire · 2026/9/1
  • Rating change
    CCORF Maintains 10x Genomics(TXG.US) With Buy Rating, Raises Target Price to $60
    Market Newswire · 2026/8/10
  • Rating change
    BofA Securities Maintains 10x Genomics(TXG.US) With Hold Rating, Announces Target Price $80
    Market Newswire · 2026/10/9
  • A Quick Look at Today's Ratings for 10x Genomics(TXG.US), With a Forecast Between $60 to $100
    Market Newswire · 2026/11/7
  • Rating change
    William Blair Maintains 10x Genomics(TXG.US) With Buy Rating
    Market Newswire · 2026/9/30
  • UBS Maintains 10x Genomics(TXG.US) With Hold Rating, Maintains Target Price $61
    Market Newswire · 2026/11/9
  • Rating change
    TD Cowen Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $47
    Market Newswire · 2026/7/15
  • Rating change
    A Quick Look at Today's Ratings for 10x Genomics(TXG.US), With a Forecast Between $50 to $53
    Market Newswire · 2026/8/8
  • Rating change
    J.P. Morgan Reaffirms Their Hold Rating on 10x Genomics (TXG)
    TipRanks · 2026/10/17
  • J.P. Morgan Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $65
    Market Newswire · 2026/11/9
  • Rating change
    Leerink Partners Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $90
    Market Newswire · 2026/9/29
  • Rating change
    Morgan Stanley Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $20.5
    Market Newswire · 2026/5/12
  • Rating change
    A Quick Look at Today's Ratings for 10x Genomics(TXG.US), With a Forecast Between $23 to $32
    Market Newswire · 2026/5/9
  • Rating change
    CCORF Maintains 10x Genomics(TXG.US) With Buy Rating, Maintains Target Price $32
    Market Newswire · 2026/6/10
  • Rating change
    Barclays Maintains 10x Genomics(TXG.US) With Buy Rating, Raises Target Price to $40
    Market Newswire · 2026/6/24
  • Rating change
    BofA Securities Maintains 10x Genomics(TXG.US) With Hold Rating
    Market Newswire · 2026/5/14

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 20:02:38 · For reference only, not investment advice and not tailored to your situation.

10x Genomics discussion 0 comments

Add a comment